• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

SAGES

Reimagining surgical care for a healthier world

  • Home
    • COVID-19 Annoucements
    • Search
    • SAGES Home
    • SAGES Foundation Home
  • About
    • Who is SAGES?
    • SAGES Mission Statement
    • Advocacy
    • Strategic Plan, 2020-2023
    • Committees
      • Request to Join a SAGES Committee
      • SAGES Board of Governors
      • Officers and Representatives of the Society
      • Committee Chairs and Co-Chairs
      • Full Committee Rosters
      • SAGES Past Presidents
    • Donate to the SAGES Foundation
    • Awards
      • George Berci Award
      • Pioneer in Surgical Endoscopy
      • Excellence In Clinical Care
      • International Ambassador
      • IRCAD Visiting Fellowship
      • Social Justice and Health Equity
      • Excellence in Community Surgery
      • Distinguished Service
      • Early Career Researcher
      • Researcher in Training
      • Jeff Ponsky Master Educator
      • Excellence in Medical Leadership
      • Barbara Berci Memorial Award
      • Brandeis Scholarship
      • Advocacy Summit
      • RAFT Annual Meeting Abstract Contest and Awards
  • Meetings
    • NBT Innovation Weekend
    • SAGES Annual Meeting
      • 2023 Scientific Session Call For Abstracts
      • 2023 Emerging Technology Call For Abstracts
    • CME Claim Form
    • Industry
      • Advertising Opportunities
      • Exhibit Opportunities
      • Sponsorship Opportunities
    • Future Meetings
    • Past Meetings
      • SAGES 2022
      • SAGES 2021
    • Related Meetings Calendar
  • Join SAGES!
    • Membership Benefits
    • Membership Applications
      • Active Membership
      • Affiliate Membership
      • Associate Active Membership
      • Candidate Membership
      • International Membership
      • Medical Student Membership
    • Member News
      • Member Spotlight
      • Give the Gift of SAGES Membership
  • Patients
    • Healthy Sooner – Patient Information for Minimally Invasive Surgery
    • Patient Information Brochures
    • Choosing Wisely – An Initiative of the ABIM Foundation
    • All in the Recovery: Colorectal Cancer Alliance
    • Find a SAGES Member
  • Publications
    • SAGES Stories Podcast
    • SAGES Clinical / Practice / Training Guidelines, Statements, and Standards of Practice
    • Patient Information Brochures
    • TAVAC – Technology and Value Assessments
    • Surgical Endoscopy and Other Journal Information
    • SAGES Manuals
    • SCOPE – The SAGES Newsletter
    • COVID-19 Annoucements
    • Troubleshooting Guides
  • Education
    • OpiVoid.org
    • SAGES.TV Video Library
    • Safe Cholecystectomy Program
      • Safe Cholecystectomy Didactic Modules
    • Masters Program
      • SAGES Facebook Program Collaboratives
      • Acute Care Surgery
      • Bariatric
      • Biliary
      • Colorectal
      • Flexible Endoscopy (upper or lower)
      • Foregut
      • Hernia
      • Robotics
    • Educational Opportunities
    • HPB/Solid Organ Program
    • Courses for Residents
      • Advanced Courses
      • Basic Courses
    • Video Based Assessments (VBA)
    • Robotics Fellows Course
    • MIS Fellows Course
    • Facebook Livestreams
    • Free Webinars For Residents
    • SMART Enhanced Recovery Program
    • SAGES OR SAFETY Video
    • SAGES at Cine-Med
      • SAGES Top 21 MIS Procedures
      • SAGES Pearls
      • SAGES Flexible Endoscopy 101
      • SAGES Tips & Tricks of the Top 21
  • Opportunities
    • NEW-Area of Concentrated Training Seal (ACT)-Advanced Flexible Endoscopy-Coming Soon!
    • SAGES Fellowship Certification for Advanced GI MIS and Comprehensive Flexible Endoscopy
    • Multi-Society Foregut Fellowship Certification
    • SAGES Research Opportunities
    • Fundamentals of Laparoscopic Surgery
    • Fundamentals of Endoscopic Surgery
    • Fundamental Use of Surgical Energy
    • Job Board
    • SAGES Go Global: Global Affairs and Humanitarian Efforts
  • Search
    • Search All SAGES Content
    • Search SAGES Guidelines
    • Search the Video Library
    • Search the Image Library
    • Search the Abstracts Archive
  • Store
    • “Unofficial” Logo Products
  • Log In

Gastric Electrical Stimulation With Enterra for Drug-resistant Gastroparesis

Nv G Jayanthi, MD FRCS, Sp L Dexter, MD FRCS, Ai Sarela, MD FRCS. Department of Upper Gastrointestinal, Metabolic & Bariatric Surgery, St James’s University Hospital, Leeds, UK

 

Introduction: Drug-resistant gastroparesis is a debilitating condition. Several clinical studies have demonstrated that most, but not all, patients get significant relief from vomiting by gastric electrical stimulation (GES) with the EnterraTM device (Medtronic). EnterraTM therapy has been approved by the U.S. Food & Drug Administration on a humanitarian device exemption basis. Selection criteria for EnterraTM therapy remain uncertain and trial of temporary GES may be of predictive value. We commenced our EnterraTM programme in May 2008, with a policy of routine temporary GES trial, and present our early results.

Patients & Methods: Consecutive patients referred to a specialist upper gastrointestinal surgery unit, at a university hospital in the UK, between May 2008 and June 2011, for consideration of EnterraTM therapy were identified from a prospectively-maintained database. Patients were referred by gastroenterologists, who believed that medical therapy had been exhausted. The diagnosis of gastroparesis was confirmed and the extent of gastric emptying was measured by a radionuclide-labelled meal and gastric scintigraphy. Clinically suitable patients underwent temporary GES, by an endoscopically-placed electrode. A gastroparesis cardinal symptom index diary was used to evaluate clinical benefit and select patients for permanent EnterraTM therapy. The permanent device was implanted laparoscopically, with electrodes placed in the gastric wall at 9cm and 10cm proximal to pylorus along the lesser and greater curvature, respectively. Position of the electrodes was confirmed by on-table endoscopy. A previously published energy algorithm (Abidi, 2006) was used to modify the stimulation program during follow-up.

Results: A total of 63 patients with medical therapy-resistant gastroparesis were referred for EnterraTM therapy during the study period. One patient died whilst awaiting transfer. To date, 42 patients have undergone temporary GES. There was clinically-meaningful symptom improvement in 31 patients (74%), who were selected for permanent placement of the EnterraTM device. Laparoscopic placement of the permanent device has been completed in 29 patients. 22 patients have been assessed following permanent EnterraTM therapy. At a median follow up of 31 weeks, clinically-significant symptomatic improvement was noted in 16 patients (73%). One patient has required placement of a feeding jejunostomy following failure of symptom resolution despite sequential increase in energy delivery.

Conclusions: Gastric electrical stimulation with EnterraTM provides clinically significant symptom resolution in the majority of patients with severe gastroparesis. Patient-selection for implantation of a permanent EnterraTM device is aided by a prior trial temporary GES, with an endoscopically-placed electrode. However, despite use of selection measures, patients need to be cautioned about uncertainty of the ultimate outcome.

 


Session Number: SS18 – Foregut
Program Number: S102

189

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pinterest
  • WhatsApp
  • Reddit

Related

« Return to SAGES 2012 abstract archive

Our Mission

Innovate, educate and collaborate to improve patient care.

Recently, on SAGES…

Critical View of Safety (CVS) Challenge QR Code

The SAGES Critical View of Safety Challenge – Donate Your Lap Chole Videos!

The Society of American Gastrointestinal and Endoscopic Surgeons is hosting the first Artificial Intelligence Data Challenge conducted by surgeons. The aim of this challenge is to generate a large and diverse dataset of laparoscopic cholecystectomy videos, annotated with respect to the subcomponents of the Critical View of Safety (CVS). Computer scientists from all over the […]

Respuesta de SAGES al Estudio NordICC sobre el beneficio de las colonoscopias de detecciĂłn

SAGES desea aclarar los resultados del estudio NordICC y colocarlos en contexto de los esfuerzos de varias agencias nacionales para reducir el riesgo de cáncer colorrectal – la segunda causa de muerte por cáncer más frecuente en los Estados Unidos-, mediante la promociĂłn de la detecciĂłn y tratamiento oportuno de las lesiones.

SAGES Response to NordICC Study Regarding Benefit of Screening Colonoscopies

The NordICC Study recently published in The New England Journal of Medicine and widely reported on by media outlets has raised questions regarding the benefit of screening colonoscopy in lowering the risk of colorectal cancer and cancer-related deaths among otherwise healthy and symptom-free men and women aged 55 to 64. Provocative headlines and commentaries have […]

Contact SAGES

Society of American Gastrointestinal and Endoscopic Surgeons
11300 W. Olympic Blvd Suite 600
Los Angeles, CA 90064 USA
webmaster@sages.org
Tel: (310) 437-0544

Find Us Around the Web!

  • Facebook
  • Twitter
  • YouTube

Important Links

SAGES 2023 Meeting Information

Healthy Sooner: Patient Information

SAGES Guidelines, Statements, & Standards of Practice

SAGES Manuals

 

  • taTME Study Info
  • Foundation
  • SAGES.TV
  • MyCME
  • Educational Activities

Copyright © 2023 Society of American Gastrointestinal and Endoscopic Surgeons